"Basal Ganglia Diseases" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Diseases of the BASAL GANGLIA including the PUTAMEN; GLOBUS PALLIDUS; claustrum; AMYGDALA; and CAUDATE NUCLEUS. DYSKINESIAS (most notably involuntary movements and alterations of the rate of movement) represent the primary clinical manifestations of these disorders. Common etiologies include CEREBROVASCULAR DISORDERS; NEURODEGENERATIVE DISEASES; and CRANIOCEREBRAL TRAUMA.
| Descriptor ID |
D001480
|
| MeSH Number(s) |
C10.228.140.079
|
| Concept/Terms |
Basal Ganglia Diseases- Basal Ganglia Diseases
- Basal Ganglia Disease
- Basal Ganglia Disorders
- Basal Ganglia Disorder
|
Below are MeSH descriptors whose meaning is more general than "Basal Ganglia Diseases".
Below are MeSH descriptors whose meaning is more specific than "Basal Ganglia Diseases".
This graph shows the total number of publications written about "Basal Ganglia Diseases" by people in this website by year, and whether "Basal Ganglia Diseases" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1998 | 1 | 0 | 1 |
| 1999 | 0 | 1 | 1 |
| 2000 | 1 | 1 | 2 |
| 2003 | 0 | 1 | 1 |
| 2004 | 1 | 0 | 1 |
| 2006 | 0 | 1 | 1 |
| 2016 | 2 | 0 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Basal Ganglia Diseases" by people in Profiles.
-
Scopolamine for Management of Extrapyramidal Side Effects as a Result of Antipsychotic Medication Use: A Case Report and Brief Review of the Literature. Prim Care Companion CNS Disord. 2016; 18(3).
-
Fulminant corticobasal degeneration: Agrypnia excitata in corticobasal syndrome. Neurology. 2016 Mar 22; 86(12):1164-6.
-
Quetiapine treatment of psychosis associated with dementia: a double-blind, randomized, placebo-controlled clinical trial. Am J Geriatr Psychiatry. 2006 Sep; 14(9):767-76.
-
A comparison of extrapyramidal symptoms in older outpatients treated with quetiapine or risperidone. Curr Med Res Opin. 2004 Sep; 20(9):1483-91.
-
Psychosis in elderly patients: classification and pharmacotherapy. J Geriatr Psychiatry Neurol. 2003 Dec; 16(4):199-206.
-
Neurocysticercosis. South Med J. 2000 Jul; 93(7):666-8.
-
An overview of side effects caused by typical antipsychotics. J Clin Psychiatry. 2000; 61 Suppl 8:5-11; discussion 12-3.
-
Comparison of risperidone and placebo for psychosis and behavioral disturbances associated with dementia: a randomized, double-blind trial. Risperidone Study Group. J Clin Psychiatry. 1999 Feb; 60(2):107-15.
-
Neurologic outcomes in children with post-pump choreoathetosis. J Pediatr. 1998 Jan; 132(1):162-4.
-
Serotonin syndrome produced by a combination of fluoxetine and lithium. Am J Psychiatry. 1993 Oct; 150(10):1565.